Arvaya Healthcare (Bijoy Hans) Files Corrigendum, Reports Q4 FY26 Results

Arvaya Healthcare Limited, previously known as Bijoy Hans Limited, has issued a corrigendum to its financial results for the quarter and year ended March 31, 2026. The update rectifies an inadvertent error in the reported Earnings Per Share (EPS).

What just happened

The company corrected its Q4 FY26 EPS figures and presented its financial snapshot. For the quarter ended March 31, 2026, standalone revenue was ₹0.00 crore, while consolidated revenue stood at ₹9.11 crore. The standalone profit was a loss of ₹0.63 crore, contrasted with a consolidated profit of ₹1.47 crore.

Why this matters

This filing is significant as it shows the impact of recent strategic acquisitions. The consolidated profit of ₹1.47 crore indicates that the newly acquired businesses are contributing positively to the bottom line, despite the negligible standalone revenue. The name change to Arvaya Healthcare Limited also marks a strategic shift.

The backstory

Effective March 4, 2026, Arvaya Healthcare acquired 100% stakes in Health Secure Hospitals Private Limited, Arvaya Health and Wellness Private Limited, and Tec-Pool Solutions Private Limited. The company officially changed its name from Bijoy Hans Limited to Arvaya Healthcare Limited on May 11, 2026. Additionally, authorized share capital was increased from ₹60 crore to ₹200 crore, approved by the board on March 17, 2026, and shareholders on April 19, 2026.

What changes now

Investors have corrected EPS data for Q4 FY26. The consolidated figures now accurately reflect the performance of the acquired healthcare entities. The increased authorized capital may signal future expansion plans.

Risks to watch

Pending litigation claims from medical consultants amount to approximately ₹3.72 crore, presenting a contingent liability. The company also recognized provisional goodwill of about ₹20.32 crore from the acquisitions, which will require future impairment testing.

Peer comparison

Specific peer comparison data was not available in the filing.

Context metrics (time-bound)

The consolidated figures reflect operations for 27 days post-acquisition (March 4, 2026, to March 31, 2026).

What to track next

Investors should closely monitor the performance of the acquired subsidiaries and developments in the pending litigation. Future announcements regarding capital deployment or expansion plans will also be key.